Cabozantinib and Vandetanib in medullary thyroid carcinoma: mitochondrial function and its potential as a therapeutic target towards novel strategies to design anti-CSCs drugs

Ekaterini Christina Tampaki, Athanasios Tampakis, Raoul Droeser, Efstratios Patsouris, and Gregory Kouraklis B Department of Propaedeutic Surgery, Laikon General Hospital, School of Medicine, National and Kapodistrian University of Athens, Greece; National Organization for the Provision of Healthcare Services, Department of Planning and Monitoring of Medicines Dispensing, Medicines Division, Greece; Department of General and Visceral Surgery, University Hospital of Basel, Switzerland; Institute for Surgical Research and Hospital Management ICFS, Basel, Switzerland; A Department of Pathology, Laiko General Hospital, School of Medicine, National and Kapodistrian University of Athens, Greece